Latest Industry Insights
Industry Insight
How the First Customized Gene Therapy Was Created in Six Months
We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.
Industry Insight
Precision Medicine at Novo Nordisk Uses AI To Combat Obesity
Novo Nordisk’s Transformational Prevention Unit (TPU) integrates AI, omics, and genomics to predict obesity risk and tailor interventions. By focusing on personalized solutions, TPU aims to prevent obesity and reduce the incidence of related diseases
Industry Insight
Unlocking Next-Gen Capabilities in LC-MS-Based Proteomics
In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.
Industry Insight
A Nutrient-Based Alternative to Weight Loss Drugs
Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own appetite-regulating mechanisms, offering a new path to long-term health and sustainable weight management.
Industry Insight
Unlocking Deep Proteomic Analysis for Population-Scale Studies
Seer joined Technology Networks for a conversation about its new Proteograph® Product Suite at ASMS 2025.
Industry Insight
Could the Future of Longevity Lie in Tackling Necrosis?
As the global population ages, the need for innovative solutions to extend health span and combat age-related diseases has never been more urgent. LinkGevity, a pioneering AI-enabled drug discovery company, is at the forefront of this challenge.
Industry Insight
iPSC Technology Overcomes Cell Therapy Manufacturing Hurdles
Discover how induced pluripotent stem cell technology is solving scale and consistency issues in mesenchymal stem/stromal cell therapy manufacturing and learn about Cynata’s ongoing clinical trials.
Industry Insight
Funding Will Advance Third-Party Verified Sustainability in Science
James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.
Industry Insight
The Probiotic Designed To Work When Your Gut Is Under Attack
Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, FerrocalmTM, and how its innovative strategy could reshape the future of gut health.
Industry Insight
Presenting a Universal Cell Engineering Solution
Portal Bio’s microfluidic technology enhances drug discovery and cell engineering by enabling efficient, scalable molecular delivery for sensitive cell types.
Advertisement
